oxidopamine and sdz glc 756

oxidopamine has been researched along with sdz glc 756 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dixon, AK; Gull, P; Hoyer, D; Jaton, AL; Kalkman, HO; Markstein, R; Rüdeberg, C; Urwyler, S	1

Other Studies

1 other study(ies) available for oxidopamine and sdz glc 756

Article	Year
SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:1-2 Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Cattle; Cerebral Cortex; Dopamine; Dopamine Agents; Dopamine Agonists; In Vitro Techniques; Male; Mice; Muscle, Smooth, Vascular; Neostriatum; Norepinephrine; Oxidopamine; Prolactin; Quinolines; Radioligand Assay; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin; Stereotyped Behavior; Sympatholytics	1996

Article

Year

SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors.

Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:1-2

Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Cattle; Cerebral Cortex; Dopamine; Dopamine Agents; Dopamine Agonists; In Vitro Techniques; Male; Mice; Muscle, Smooth, Vascular; Neostriatum; Norepinephrine; Oxidopamine; Prolactin; Quinolines; Radioligand Assay; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin; Stereotyped Behavior; Sympatholytics

1996